Skip to main content

Peer Review reports

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

Original Submission
7 Jul 2015 Submitted Original manuscript
7 Sep 2015 Author responded Author comments - Elisabeth Giraud-Baro
4 Aug 2015 Reviewed Reviewer Report - Kenji Hashimoto
9 Aug 2015 Reviewed Reviewer Report - Xiaojun Huang
11 Aug 2015 Reviewed Reviewer Report - Victor Lasebikan
Resubmission - Version 2
7 Sep 2015 Submitted Manuscript version 2
9 Oct 2015 Author responded Author comments - Elisabeth Giraud-Baro
Resubmission - Version 3
9 Oct 2015 Submitted Manuscript version 3
15 Nov 2015 Author responded Author comments - Elisabeth Giraud-Baro
Resubmission - Version 4
15 Nov 2015 Submitted Manuscript version 4
4 Dec 2015 Author responded Author comments - Elisabeth Giraud-Baro
Resubmission - Version 5
4 Dec 2015 Submitted Manuscript version 5
Publishing
8 Jan 2016 Editorially accepted
15 Jan 2016 Article published 10.1186/s12888-016-0712-1

You can find further information about peer review here.

Back to article page